Editor’s Pick

In this insightful overview, Grayson dives into StockCharts’ powerful scanning capabilities. He shows you how to navigate the markets quickly with the sample scan library, and automate your stock screening…

My main question going into this weekend was, “Will the S&P 500 finish the week above its 200-day moving average?”  And while the S&P 500 did indeed finish the week…

Norbert Michel and Jerome Famularo Supporters often justify the Trump administration’s trade policies by claiming that increased trade with China, starting in 2001, decimated US manufacturing. But as this blog…

Colleen Hroncich At first glance, LUMIN Schools might look like other traditional schools. But when you dig a little deeper, you find unique ways they’re working to help their students…

Clark Packard and Alfredo Carrillo Obregon Relative to the so-called “Liberation Day” tariffs and subsequent retaliatory increases, the recent trade “truce” announced by Washington and Beijing is certainly an improvement.…

Nicholas Anthony Financial privacy has attracted increased attention in recent months for both better and worse. In some ways, it seems the concerns held by privacy activists are finally being…

Jeremy Horpedahl Trump’s trade war has a new target: Barbie dolls. And not just Barbie dolls, but toys of all kinds. As the new tariffs (no longer over 100 percent,…

The bullish signals stacked up in April and May, but most long-term breadth indicators are still bearish. SPY and QQQ showed signs of capitulation in early April and rebounded into…

The financial media is flooded with commentary questioning whether the current rise in stock indexes is sustainable enough to mark the beginning of a new bull market. In short, have…

Jeffrey A. Singer Naloxone has saved tens of thousands of lives. Yet, more than 50 years after the FDA approved it in injectable form, government rules still make the most affordable…